CHARLES SCHWAB INVESTMENT MANAGEMENT INC - TALIS BIOMEDICAL CORP ownership

Back to all holdings Add to watchlist

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 42 filers reported holding TALIS BIOMEDICAL CORP in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Filings

EDGAR links

External links

Quarter-by-quarter ownership

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of TALIS BIOMEDICAL CORP
	Value		Shares		Weighting
Q1 2022	$45,000	-69.6%	31,324	-14.7%	0.00%	–
Q4 2021	$148,000	-35.7%	36,714	0.0%	0.00%	–
Q3 2021	$230,000	-78.3%	36,714	-61.8%	0.00%	–
Q2 2021	$1,059,000	-12.0%	95,996	+2.5%	0.00%	–
Q1 2021	$1,204,000	–	93,659	–	0.00%	–
Download

Other shareholders

TALIS BIOMEDICAL CORP shareholders Q3 2021
Name	Shares	Value	Weighting ↓
Greenlight Capital	2,235,783	$1,095,534	0.06%
Baker Brothers Advisors	7,624,835	$3,736,169	0.02%
PRELUDE CAPITAL MANAGEMENT, LLC	223,934	$109,728	0.01%
ArrowMark Colorado Holdings LLC	478,862	$234,642	0.00%
WELLS FARGO & COMPANY/MN	167	$82	0.00%
NORTHERN TRUST CORP	27,860	$13,652	0.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0	$0	0.00%
GEODE CAPITAL MANAGEMENT, LLC	144,416	$70,763	0.00%
STATE STREET CORP	49,536	$24,273	0.00%
MILLENNIUM MANAGEMENT LLC	163,663	$80	0.00%

View complete list of TALIS BIOMEDICAL CORP shareholders